Tumor immunology with particular reference to malignant melanoma.
D000818:Animals; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002273:Carcinogens; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology / Q000628:therapy; D006649:Histocompatibility Antigens; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D008748:Methylcholanthrene; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology / Q000628:therapy; D009626:Terminology as Topic; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D002273:Carcinogens; D006649:Histocompatibility Antigens; D008748:Methylcholanthrene